# Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease

> **NCT03903211** · PHASE2 · COMPLETED · sponsor: **Jae Seung Kim** · enrollment: 84 (actual)

## Conditions studied

- Cognitively Normal
- Mild Cognitive Impairment
- Alzheimer Disease

## Interventions

- **DRUG:** [18F]PI-2620

## Key facts

- **NCT ID:** NCT03903211
- **Lead sponsor:** Jae Seung Kim
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-09
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03903211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03903211, "Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03903211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*